AngioDynamics, Inc. - Common Stock · Transaction Jul 16, 2025 · Filed Jul 25, 2025 · $1,001 to $15,000
NASDAQ NMS - GLOBAL MARKET · ANGO
-1.04% · -$0.1600 · Vol 84.8K
Live · updated 12:25:25 ET
AngioDynamics Inc
Health Care
$15.28
Follow $ANGO
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $ANGO by emailVeridion Score
BETAMEDIUM CONF · 5 of 6 factors measuredFri Sep 18 · last completed session · daily score · 2d 15h old · ANGO
MethodologySentiment absence reason unknown
ANGO
AngioDynamics Inc
Fri Sep 18 · last completed session · daily score · 2d 15h old
Upper range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
76/ 100
Veridion Score
Upper range · MEDIUM confidence · 5 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 5 of 6 factors measured · Fri Sep 18 · last completed session · daily score · 2d 15h old
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is ANGO moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About AngioDynamics Inc
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSListed since
2004
Employees
632
Country
US
AngioDynamics Inc is a dynamic, diversified medical technology company committed to expanding treatment options and improving patient outcomes and quality of life by designing, manufacturing, and selling products and technologies that aid clinicians in the treatment of patients with cardiovascular disease and cancer diagnoses. The company's execution plan is built on R&D, clinical and regulatory pathway expansion, and customer-centric sales performance. The company's product offerings fall within two segments, Med Tech and Med Device. Med Tech includes Auryon and Thrombectomy, while Med Device has Peripheral Products (Interventional Devices), Ports, and Microwave Ablation. Geographically operates in the USA and Other countries; maximum revenue from the USA.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$15.44
Day high
$15.49
Day low
$15.22
Previous close
$15.44
52W high
$16.13
-5.27% from high
52W low
$9.70
87% of range
Market cap
$638.2M
EPS
$-0.7100
Beta
0.47
Shares out
41.3M
Volume
84.8K
0.21× rel vol
Avg volume
401.8K
VWAP
$15.33
Price history computed in-house
1W
-1.48%
1M
-2.98%
3M
+23.52%
1Y
+41.88%
YTD
+19.00%
SMA 50 $15.03 · above
SMA 200 $12.37 · above
52W position 87%
ANGO overview
Related filings and maps
Public disclosures
Congress activity in ANGO
Official filing ↗
ANGO · Transaction Jul 16, 2025 · Filed Jul 25, 2025 · $1,001 to $15,000
AngioDynamics, Inc. - Common Stock · Transaction Jun 27, 2025 · Filed Jul 25, 2025 · $1,001 to $15,000
Federal contracts
ANGO contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ANGO in this window.
Lobbying spend
ANGO lobbying filings, year to date.
Registered lobbying filings matched to AngioDynamics Inc.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ANGO in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for ANGO.
Options
Sovereign unlock shows live options positioning for ANGO.